Bolli, Geremia B.

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 818

Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion

Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 433

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naive people with type 2 diabetes on oral glucose-lowering drugs: A randomized controlled trial (EDITION 3)

Bolli, G. B., Riddle, M. C., Bergenstal, R. M., Ziemen, M., Sestakauskas, K., Goyeau, H., Home, P. D., & on behalf of the EDITION 3 study investigators (2015) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 301

The “Dawn-Phenomenon” – a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus

Bolli, G. B., & Gerich, J. E. (1984) · New England Journal of Medicine

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 235

New insulin glargine 300 units/ml versus glargine 100 units/ml in people with type 1 diabetes: A randomized, phase 3a, open-label clinical trial (edition 4)

Home, P. D., Bergenstal, R. M., Bolli, G. B., Ziemen, M., Rojeski, M., Espinasse, M., & Riddle, M. C. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 221

Reversibility of unawareness of hypoglycemia in patients with insulinomas.

Mitrakou, A., Fanelli, C., Veneman, T., Perriello, G., Calderone, S., Platanisiotis, D., Rambotti, A., Raptis, S., Brunetti, P., Cryer, P., et al. (1993) · New England Journal of Medicine

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 221

Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.

Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Di Vincenzo, A., Modarelli, F., Ciofetta, M., Lepore, M., Annibale, B., Torlone, E., et al. (1994) · Diabetologia

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 212

Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans

Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Ciofetta, M., Modarelli, F., Di Vincenzo, A., Annibale, B., Lepore, M., Lalli, C., et al. (1994) · Diabetologia

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 193

Insulin glargine

Bolli, G. B., & Owens, D. R. (2000) · The Lancet

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 186

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure

McMurray, J. J. V., Ponikowski, P., Bolli, G. B., Lukashevich, V., Kozlovski, P., Kothny, W., Lewsey, J. D., & Krum, H. (2018) · JACC: Heart Failure

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 165

Efficacy and safety of lixisenatide once daily vs. placebo in people with type 2 diabetes insufficiently controlled on metformin (GetGoal-F1)

Bolli, G. B., Munteanu, M., Dotsenko, S., Niemoeller, E., Boka, G., Wu, Y., & Hanefeld, M. (2014) · Diabetic Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 144

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Maddaloni, E., Bolli, G. B., Frier, B. M., Little, R. R., Leslie, R. D., Pozzilli, P., & Buzzetti, R. (2022) · Diabetes, Obesity and Metabolism

Diabetes and associated disordersPancreatic function and diabetes

Cited by 135

Contribution of cortisol to glucose counterregulation in humans

De Feo, P., Perriello, G., Torlone, E., Ventura, M. M., Fanelli, C., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1989) · American Journal of Physiology-Endocrinology and Metabolism

Adrenal Hormones and DisordersDiabetes Management and Research

Cited by 134

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes

Bolli, G. B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J. L., & Home, P. D. (2009) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 119

Demonstration of a role for growth hormone in glucose counterregulation

De Feo, P., Perriello, G., Torlone, E., Ventura, M. M., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1989) · American Journal of Physiology-Endocrinology and Metabolism

Growth Hormone and Insulin-like Growth FactorsDiabetes Management and Research

Cited by 116

One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension

Riddle, M. C., Yki‐Järvinen, H., Bolli, G. B., Ziemen, M., Muehlen‐Bartmer, I., Cissokho, S., & Home, P. D. (2015) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 110

Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Bolli, G. B., Tsalikian, E., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes Management and Research

Cited by 108

Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.

Bottini, P., Boschetti, E., Pampanelli, S., Ciofetta, M., Sindaco, P. D., Scionti, L., Brunetti, P., & Bolli, G. B. (1997) · Diabetes

Diabetes Management and ResearchCardiovascular Syncope and Autonomic Disorders

Cited by 107

PHYSIOLOGY OF GLUCOSE COUNTERREGULATION TO HYPOGLYCEMIA

Bolli, G. B., & Fanelli, C. G. (1999) · Endocrinology and Metabolism Clinics of North America

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 99

Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Bolli, G., De Feo, P., Perriello, G., De Cosmo, S., Compagnucci, P., Santeusanio, F., Brunetti, P., & Unger, R. H. (1984) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes Management and Research

Cited by 64

Long-Term Intensive Therapy of IDDM Patients With Clinically Overt Autonomic Neuropathy: Effects on Hypoglycemia Awareness and Counterregulation

Fanelli, C., Pampanelli, S., Lalli, C., Sindaco, P. D., Ciofetta, M., Lepore, M., Porcellati, F., Bottini, P., Di Vincenzo, A., Brunetti, P., et al. (1997) · Diabetes

Diabetes Management and ResearchCardiovascular Syncope and Autonomic Disorders

Cited by 63

Insulin Infusion Set Use: European Perspectives and Recommendations

Deiss, D., Adolfsson, P., Alkemade-van Zomeren, M., Bolli, G. B., Charpentier, G., Cobelli, C., Danne, T., Girelli, A., Mueller, H., Verderese, C. A., et al. (2016) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchIntravenous Infusion Technology and Safety

Cited by 62

Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors

Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., & Brunetti, P. (1982) · Diabetes

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 56

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes

Porcellati, F., Lucidi, P., Cioli, P., Candeloro, P., Marinelli Andreoli, A., Marzotti, S., Ambrogi, M., Bolli, G. B., & Fanelli, C. G. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 52